(S (NP (NP (NP (NNP Social) (NNP Network) (NNP Analysis)) (-LRB- -LRB-) (NP (NNP SNA)) (-RRB- -RRB-)) (PP (IN of) (NP (NNS organizations)))) (VP (MD can) (VP (VB attract) (NP (JJ great) (NN interest)) (PP (IN from) (NP (NN government) (NNS agencies) (CC and) (NNS scientists))) (PP (IN for) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VP (VB boost) (NP (JJ translational) (NN research))) (CC and) (VP (VB accelerate) (NP (NP (DT the) (NN process)) (PP (IN of) (S (VP (VBG converting) (NP (NN research)) (S (VP (TO to) (VP (VB care)))))))))))))))) (. .))
(S (PP (IN For) (NP (NP (NNP SNA)) (PP (IN of) (NP (DT a) (JJ particular) (NN disease) (NN area))))) (, ,) (NP (PRP we)) (VP (VBP need) (S (VP (TO to) (VP (VB identify) (NP (NP (DT the) (JJ key) (NN research) (NNS groups)) (PP (IN in) (NP (DT that) (NN area)))) (PP (IN by) (S (VP (VBG mining) (NP (DT the) (NN affiliation) (NN information)) (PP (IN from) (NP (NNP PubMed)))))))))) (. .))
(S (NP (DT This)) (ADVP (RB not) (RB only)) (VP (VBZ involves) (S (VP (VP (VBG recognizing) (NP (DT the) (NN organization) (NNS names)) (PP (IN in) (NP (DT the) (NN affiliation) (NN string)))) (, ,) (CONJP (CC but) (RB also)) (VP (VBG resolving) (NP (NNS ambiguities)) (S (VP (TO to) (VP (VB identify) (NP (DT the) (NN article)) (PP (IN with) (NP (DT a) (JJ unique) (NN organization)))))))))) (. .))
(S (NP (PRP We)) (VP (VBP present) (ADVP (RB here)) (NP (NP (NP (DT a) (NN process)) (PP (IN of) (NP (NN normalization)))) (SBAR (WHNP (WDT that)) (S (VP (VBZ involves) (NP (NN clustering)) (PP (VBN based) (PP (IN on) (NP (NP (JJ local) (NML (NN sequence) (NN alignment)) (NNS metrics)) (CC and) (NP (NP (JJ local) (NN learning)) (VP (VBN based) (PP (IN on) (S (VP (VBG finding) (NP (JJ connected) (NNS components))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP demonstrate) (NP (NP (DT the) (NN application)) (PP (IN of) (NP (DT the) (NN method)))) (PP (IN by) (S (VP (VP (VBG analyzing) (NP (NP (NNS organizations)) (VP (VBN involved) (PP (IN in) (NP (NN angiogenensis) (NN treatment)))))) (, ,) (CC and) (VP (VBG demonstrating) (NP (NP (DT the) (NN utility)) (PP (IN of) (NP (NP (DT the) (NNS results)) (PP (IN for) (NP (NP (NNS researchers)) (PP (IN in) (NP (NP (DT the) (NML (NN pharmaceutical) (CC and) (NN biotechnology)) (NNS industries)) (CC or) (NP (JJ national) (NN funding) (NNS agencies)))))))))))))) (. .))
